qwertyuiopasdfghjklzxcvbnmqwerty

uiopasdfghjklzxcvbnmqwertyuiopasd
fghjklzxcvbnmqwertyuiopasdfghjklzx
cvbnmqwertyuiopasdfghjklzxcvbnmq
wertyuiopasdfghjklzxcvbnmqwertyui
opasdfghjklzxcvbnmqwertyuiopasdfg
hjklzxcvbnmqwertyuiopasdfghjklzxc
vbnmqwertyuiopasdfghjklzxcvbnmq
wertyuiopasdfghjklzxcvbnmqwertyui
opasdfghjklzxcvbnmqwertyuiopasdfg
NIFTY OUTLOOK
hjklzxcvbnmqwertyuiopasdfghjklzxc
REPORT
vbnmqwertyuiopasdfghjklzxcvbnmq
th
11 July 2017
wertyuiopasdfghjklzxcvbnmqwertyui
opasdfghjklzxcvbnmqwertyuiopasdfg
hjklzxcvbnmrtyuiopasdfghjklzxcvbn
mqwertyuiopasdfghjklzxcvbnmqwert
yuiopasdfghjklzxcvbnmqwertyuiopas
 11th July 2017

NIFTY

NIFTY FUT : R1:9800 R2:9825 R3:9850

PIVOT : 9752 S1:9712 S2:9647 S3:9607

NIFTY INTRADAY CHART

NIFTY OUTLOOK
Nifty is likely to open in a marginal positive note. Momentum indicators are indicating towards a strong trading
session for bulls. Bulls are ready to show their hidden power after bear losses 9675 mark. Positional traders are
advised to cover their shorts as we are expecting nifty to show up 10,000 soon in upcoming trading sessions.

Strategy: Buy nifty around 9760 with a stop loss of 9725 for the target of 9820.

Name Current Value Change % Chg Open High Low

FTSE 100 (Jul 10) 7,370.03 19.11 0.26 7,350.92 7,388.02 7,344.31
CAC 40 (Jul 10) 5,165.64 20.48 0.4 5,160.70 5,179.34 5,147.67
DAX (Jul 10) 12,445.92 57.24 0.46 12,464.96 12,482.95 12,406.20

20,173.21 92.23 0.46 20,073.86 20,179.78 20,070.67

Nikkei 225 (Jul 11)
Straits Times (Jul
3,234.11 -12.24 -0.38 3,248.55 3,249.49 3,230.58
11)
25,784.22 284.16 1.1 25,605.19 25,788.99 25,596.21
Hang Seng (Jul 11)

Taiwan Weighted 10,385.81 95.9 0.92 10,313.08 10,392.25 10,313.08

(Jul 11)
9,793.50 20.5 0.21 9,776.00 9,807.50 9,759.00
SGX Nifty (Jul 11)

WWW.EQUITYRESEARCHLAB.COM
 11th July 2017

CORPORATE NEWS
-Cadila Healthcare: Zydus gets tentative US FDA nod for Lurasidone Hydrochloride tablets

-Alembic Pharmaceuticals receives USFDA tentative approval for Dabigatran Etexilate capsules

-SBI board approves divestment of SBI's stake in SBI Life through an IPO; offer for sale of 8 crore shares

-Patel Integrated Logistics signs letter of intent to acquire a warehouse of 35000 square feet carpet area in

Gujarat on 30-year lease basis with Sumar Logistics & Industrial Park

-Gallantt Metal - Ind-Ra affirms A- rating to company's long term borrowing

-Accel Frontline completes sale of entire shareholding in Accel systems, Singapore to Starhub

-Ramco Systems - ICRA reaffirms the long term and short term credit ratings for bank facilities

-Oriental Bank of Commerce revises 1-year MCLR rate to 8.45 percent from 8.5 percent

-Global carriers, PE hover around Jet Airways to acquire 24 percent stake: ET

-SpiceJet - Ex-promoter Maran alleges contract violation no question of dmamges

-GTL comes clean in audit, lenders to settle debt: ET

-DB Corp in talks to sell 2520MW power arm to Tata Power, CDPQ, ICICI venture: ET

-Lanco Infratech encashes suppliers bank guarantees: BS

-Inox Wind, Suzlon Energy in focus - GST concerns delay renewable auction in Gujarat: FE-IOC, Lanzatech sign

statement of intent to construct gas-to-bioethol production unit in India

WWW.EQUITYRESEARCHLAB.COM
 11th July 2017

ERL RESEARCH TEAM

Member Name Designation E-mail ID

Mr. Tuhinanshu Jain Research Head Tuhinanshu.jain@equityresearchlab.co.in
Mr. Manish Bimal Sr. Research Analyst Manish.bimal@equityresearchlab.co.in

DISCLAIMER

The information and views in this report, our website & all the service we provide are believed to be
reliable, but we do not accept any responsibility (or liability) for errors of fact or opinion. Users have
the right to choose the product/s that suits them the most. Investment in Stocks has its own risks.
Sincere efforts have been made to present the right investment perspective. The information contained
herein is based on analysis and up on sources that we consider reliable. We, however, do not vouch
for the accuracy or the completeness thereof. This material is for personal information and we are not
responsible for any loss incurred based upon it & takes no responsibility whatsoever for any financial
profit s or loss which may arise from the recommendations above. The stock price projections shown
are not necessarily indicative of future price performance. The information herein, together with all
estimates and forecasts, can change without notice.

Equity Research Lab does not purport to be an invitation or an offer to buy or sell any financial
instrument. Analyst or any person related to Equity Research Lab might be holding positions in the
stocks recommended. It is understood that anyone who is browsing through the site has done so at his
free will and does not read any views expressed as a recommendation for which either the site or its
owners or anyone can be held responsible for. Any surfing and reading of the information is the
acceptance of this disclaimer.

Our Clients (Paid or Unpaid), any third party or anyone else have no rights to forward or share our
calls or SMS or Report or Any Information Provided by us to/with anyone which is received directly
or indirectly by them. If found so then Serious Legal Actions can be taken. Any surfing and reading of
the information is the acceptance of this disclaimer.

ALL RIGHTS RESERVED.

WWW.EQUITYRESEARCHLAB.COM